SPECTRAL MEDICAL Valuation
| SD4 Stock | EUR 0.35 0.01 2.78% |
SPECTRAL MEDICAL seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of SPECTRAL MEDICAL from examining the company fundamentals such as shares owned by institutions of 13.18 %, and Return On Equity of -7.84 as well as evaluating its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that SPECTRAL MEDICAL's price fluctuation is out of control at this time. Calculation of the real value of SPECTRAL MEDICAL is based on 3 months time horizon. Increasing SPECTRAL MEDICAL's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the SPECTRAL stock is determined by what a typical buyer is willing to pay for full or partial control of SPECTRAL MEDICAL. Since SPECTRAL MEDICAL is currently traded on the exchange, buyers and sellers on that exchange determine the market value of SPECTRAL Stock. However, SPECTRAL MEDICAL's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.35 | Real 0.3 | Hype 0.35 |
The real value of SPECTRAL Stock, also known as its intrinsic value, is the underlying worth of SPECTRAL MEDICAL Company, which is reflected in its stock price. It is based on SPECTRAL MEDICAL's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of SPECTRAL MEDICAL's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of SPECTRAL MEDICAL helps investors to forecast how SPECTRAL stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of SPECTRAL MEDICAL more accurately as focusing exclusively on SPECTRAL MEDICAL's fundamentals will not take into account other important factors: SPECTRAL MEDICAL Total Value Analysis
SPECTRAL MEDICAL is at this time estimated to have takeover price of 0 with market capitalization of 62.12 M, debt of 0, and cash on hands of 3.43 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the SPECTRAL MEDICAL fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 62.12 M | 0 | 3.43 M |
SPECTRAL MEDICAL Investor Information
About 20.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.03. SPECTRAL MEDICAL had not issued any dividends in recent years. SPECTRAL MEDICAL is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.SPECTRAL MEDICAL Asset Utilization
One of the ways to look at asset utilization of SPECTRAL is to check how much profit was generated for every dollar of assets it reports. SPECTRAL MEDICAL has a negative utilization of assets of -0.74 %, losing €0.007429 for each euro of assets held by the company. Ineffective asset utilization indicates the company is being less competent with each euro of assets it has. In other words, asset utilization of SPECTRAL MEDICAL shows how unsuccessful it operates for each euro spent on its assets.SPECTRAL MEDICAL Ownership Allocation
SPECTRAL MEDICAL shows a total of 278.22 Million outstanding shares. SPECTRAL MEDICAL maintains noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.SPECTRAL MEDICAL Profitability Analysis
The company reported the revenue of 1.66 M. Net Loss for the year was (2.91 M) with profit before overhead, payroll, taxes, and interest of 1.22 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates SPECTRAL MEDICAL's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in SPECTRAL MEDICAL and how it compares across the competition.
About SPECTRAL MEDICAL Valuation
The stock valuation mechanism determines SPECTRAL MEDICAL's current worth on a weekly basis. Our valuation model uses a comparative analysis of SPECTRAL MEDICAL. We calculate exposure to SPECTRAL MEDICAL's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of SPECTRAL MEDICAL's related companies.Spectral Medical Inc. focuses on the development and commercialization of treatment for septic shock in North America. Spectral Medical Inc. was founded in 1991 and is headquartered in Toronto, Canada. SPECTRAL MEDICAL operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 18 people.
8 Steps to conduct SPECTRAL MEDICAL's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates SPECTRAL MEDICAL's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct SPECTRAL MEDICAL's valuation analysis, follow these 8 steps:- Gather financial information: Obtain SPECTRAL MEDICAL's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine SPECTRAL MEDICAL's revenue streams: Identify SPECTRAL MEDICAL's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research SPECTRAL MEDICAL's industry and market trends, including the size of the market, growth rate, and competition.
- Establish SPECTRAL MEDICAL's growth potential: Evaluate SPECTRAL MEDICAL's management, business model, and growth potential.
- Determine SPECTRAL MEDICAL's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate SPECTRAL MEDICAL's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for SPECTRAL Stock analysis
When running SPECTRAL MEDICAL's price analysis, check to measure SPECTRAL MEDICAL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SPECTRAL MEDICAL is operating at the current time. Most of SPECTRAL MEDICAL's value examination focuses on studying past and present price action to predict the probability of SPECTRAL MEDICAL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SPECTRAL MEDICAL's price. Additionally, you may evaluate how the addition of SPECTRAL MEDICAL to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |